Delivery Order SPE2DB22D3501-SPE2DB25FWS83
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $13,236.00 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Vivitrol 380 mg vial diluents, with a contract ceiling value of $4,004.68 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with a ceiling value of $6,007.02 and an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,852.93 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, issued on July 29, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily for opioid use disorder treatment and alcohol dependence,...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vivitrol is a medication used primarily in the treatment of alcohol and opioid use disorders, making this supply order critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents with a ceiling value of $1,179.61 under a firm fixed price contract. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vivitrol 380 mg vial-diluents, a medication commonly used in opioid addiction treatment programs. This firm fixed-price delivery order, valued at $1,001.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $6,007.02. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and is classified as a delivery order, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWS83Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $3,862.11. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. Vivitrol is an extended-release injectable medication used in opioid and alcohol use disorder treatment, representing a critical pharmaceutical supply for military and federal healthcare systems. This delivery order is a child contract under AmerisourceBergen's larger $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen's prime vendor status enables it to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contracting history demonstrates its capability to fulfill specialized medical procurement requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/5/25 |